Seelos Therapeutics Inc. (NASDAQ: SEEL) established initial surge of 11.81% at $1.61, as the Stock market unbolted on January 15, 2021. During the day, the stock rose to $1.62 and sunk to $1.37 before settling in for the price of $1.44 at the close. Taking a more long-term approach, SEEL posted a 52-week range of $0.42-$2.09.
It was noted that the giant of the Healthcare sector posted annual sales growth of -47.30% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 56.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -123.80%. This publicly-traded company’s shares outstanding now amounts to $46.99 million, simultaneously with a float of $46.28 million. The organization now has a market capitalization sitting at $84.19 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1901, while the 200-day Moving Average is $0.9689.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 6 workers. It has generated 62,500 per worker during the last fiscal year. For the Profitability, stocks operating margin was -7399.20 and Pretax Margin of -13668.00.
Seelos Therapeutics Inc. (SEEL) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Seelos Therapeutics Inc. industry. Seelos Therapeutics Inc.’s current insider ownership accounts for 13.38%, in contrast to 10.10% institutional ownership.
Seelos Therapeutics Inc. (SEEL) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 9/29/2020, it has been observed that the corporation posted -$0.09 earnings per share (EPS) during the time that was less the consensus figure (set at -$0.08) by -$0.01. This company achieved a net margin of -13668.00 while generating a return on equity of -3,996.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
Seelos Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -123.80% and is forecasted to reach -0.39 in the upcoming year.
Seelos Therapeutics Inc. (NASDAQ: SEEL) Trading Performance Indicators
Let’s observe the current performance indicators for Seelos Therapeutics Inc. (SEEL). It’s Quick Ratio in the last reported quarter now stands at 3.50. The Stock has managed to achieve an average true range (ATR) of 0.17.
In the same vein, SEEL’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.71, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.39 at the market close of one year from today.
Technical Analysis of Seelos Therapeutics Inc. (SEEL)
Now, what If we examine the latest scores posted by [Seelos Therapeutics Inc., SEEL]. During the last 5-days, its volume was lower the volume of 1.13 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 65.70% While, its Average True Range was 0.1621.
Raw Stochastic average of Seelos Therapeutics Inc. (SEEL) in the period of the previous 100 days is set at 68.62%, which indicates a major rise in contrast to 60.78% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 101.22% that was lower than 104.97% volatility it exhibited in the past 100-days period.